GlaxoSmithKline ( (GB:GSK) ) has shared an update.
GSK plc has announced its total voting rights and capital structure as of February 28, 2025. The company reported an issued share capital of 4,315,177,430 shares, with 173,023,905 shares held in treasury, resulting in a total of 4,142,153,525 voting rights. This information is crucial for shareholders to determine their interests under the Financial Conduct Authority’s rules, impacting their decision-making and compliance obligations.
More about GlaxoSmithKline
GlaxoSmithKline (GSK) is a global healthcare company operating in the pharmaceutical industry, focusing on the development and production of medicines, vaccines, and consumer healthcare products.
YTD Price Performance: 10.14%
Average Trading Volume: 7,985,177
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: £59.81B
Learn more about GSK stock on TipRanks’ Stock Analysis page.